1	QRP	(3s,8as)-3-(1h-indol-3-ylmethyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione	1.000
2	2IV	(3~{S},8~{a}~{S})-3-[(4-fluoranyl-1~{H}-indol-3-yl)methyl]-2,3,6,7,8,8~{a}-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione	0.955
3	3I5	(3~{S},8~{a}~{S})-3-[(5-fluoranyl-1~{H}-indol-3-yl)methyl]-2,3,6,7,8,8~{a}-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione	0.955
4	3ZI	(3~{S},8~{a}~{S})-3-[(7-fluoranyl-1~{H}-indol-3-yl)methyl]-2,3,6,7,8,8~{a}-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione	0.955
5	RQB	(3s,5s,8as)-3-[(1-methyl-1h-indol-3-yl)methyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione	0.955
6	0MV	(3s)-3-(1h-indol-3-ylmethyl)-3,4-dihydro-1h-1,4-benzodiazepine-2,5-dione	0.833
7	WMA	(3s,6s)-3-ethyl-6-[(1h-indol-3-yl)methyl]piperazine-2,5-dione	0.783
8	ZWP	3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-8h-pyrrolo[1,2-a]pyrazin-5-ium-1-olate	0.769
9	I5R	(2r)-2-(1h-indol-3-ylmethyl)-1,4-dihydropyrido[2,3-B]pyrazin-3(2h)-one	0.750
10	UYG	(3s,6s)-3-[(1h-indol-3-yl)methyl]-6-(propan-2-yl)piperazine-2,5-dione	0.750
11	0QX	2-(1h-indol-3-ylmethyl)-1h-imidazo[4,5-C]pyridine	0.739
12	TYP	Cyclo-(L-tyrosine-L-proline) inhibitor	0.739
13	CHQ	Cyclo-(L-histidine-L-proline) inhibitor	0.727
14	I5H	(5s)-5-(1h-indol-3-ylmethyl)imidazolidine-2,4-dione	0.727